| NMR Experiment |
|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
|---|
| 1 | 2D 1H-15N HSQC | 0.5 mM [U-15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |
| 2 | 3D HNCACB | 0.5 mM [U-99% 13C; U-99% 15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |
| 3 | 3D CBCA(CO)NH | 0.5 mM [U-99% 13C; U-99% 15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |
| 4 | 3D HNCA | 0.5 mM [U-99% 13C; U-99% 15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |
| 5 | 3D HN(CO)CA | 0.5 mM [U-99% 13C; U-99% 15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |
| 6 | 3D HCCH-TOCSY | 0.5 mM [U-99% 13C; U-99% 15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |
| 7 | 3D 1H-15N NOESY | 0.5 mM [U-99% 13C; U-99% 15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |
| 8 | 3D 1H-13C NOESY | 0.5 mM [U-99% 13C; U-99% 15N] MtRel ACT domain, 50 mM sodium phosphate, 350 mM sodium chloride, 5 % v/v glycerol, 0.01 % w/v sodium azide | 90% H2O/10% D2O | 350 mM | 7.5 | 1 atm | 298 | Bruker AVANCE 700 |